Longenesis
Alex Zhavoronkov, Ph.D.
Team Name:
Longenesis
Team Leader Name:
Alex Zhavoronkov, Ph.D.
Location
Baltimore, MD
Approach:
Tissue Screening
Team Leader Bio:
Alex Zhavoronkov, PhD. is the CEO and co-founder of Insilico Medicine, Inc a Baltimore-based company utilizing big data analysis and deep learning for aging research and drug discovery. He also heads the International Aging Research Portfolio (AIRP) knowledge management system for aging research and serves as the CSO of the Biogerontology Research Foundation in the UK.
Prior to Insilico Medicine, he co-founded the First Oncology Research and Advisory Center (FORAC), served as the director of ATI Technologies (Nasdaq: AMD) and as the director of GTCBio. He is also the head of research at NeuroG Neuroinformatics, a neuroinformatics company developing algorithms for cost-effective EEG devices to recognize imagined visual images and delay the onset of age-related neurodegenerative diseases.
Dr. Zhavoronkov holds two bachelor degrees from Queen’s University, a masters in biotechnology from Johns Hopkins University and a PhD in physics and mathematics from the Moscow State University and is the adjunct professor at the Moscow Institute of Physics and Technology.
Team CPMC
Stephen Michael Jackson
Team Name:
Team CPMC
Team Leader Name:
Stephen Michael Jackson
Location
Washington, D.C.
Approach:
Cannabinoids
Affiliation:
California Medical Center Research Center
Link:
N/A
Team Leader Bio:
Stephen Michael Jackson is President of StillZero, LLC and an award winning broadcast producer, creative director and expert in the fields of brand marketing, advertising and strategic communications.
Run4Life
Dundas, Canada
Team Name:
Run4Life
Team Leader Name:
Mark A. Tarnopolsky, M.D., Ph.D.
Location
Dundas, Canada
Approach:
Endurance Exercise
Affiliation:
McMaster University
Link:
N/A
Team Leader Bio:
Dr. Mark Tarnopolsky is the Clinical and Research Director of the Corkins/Lammert Family Neuromuscular and Neurometabolic Clinic at McMaster University and President and CEO of Exerkine. He holds an endowed chair at McMaster Children’s Hospital and Hamilton Health Sciences Foundation in Neuromuscular Diseases and is a Professor of Pediatrics and Medicine. He completed a PhD in cell biology and metabolism and residency training in Internal Medicine, Neurology and Physiatry.His research focuses on nutritional, exercise and pharmacological therapies for neurometabolic (primarily mitochondrial) and neuromuscular disorders, and aging. In addition, he studies the physiological and molecular aspects of mitochondrial adaptations to exercise, aging and the metabolic syndrome.
Email Contact for Team
tarnopol@mcmaster.ca
9057461295
President/CEO
Exerkine L9H1W9
SF Corp
Yuba City, CA
Team Name:
SF Corp
Team Leader Name:
Robert Brooke
Location
Yuba City, CA
Approach:
Nutritional and lifestyle intervention
Affiliation:
Stevia First Corp.
Link:
N/A
Team Leader Bio:
Robert Brooke is Co-Founder and CEO of Stevia First Corp. (“SF Corp”), a California ag-biotech company that is developing food and nutritional products related to diabetes and obesity, and including products that target lifespan-modulating genes (“geroprotectors”). Mr. Brooke previously received degrees in electrical and biomedical engineering from Georgia Tech and UCLA. He later worked in hedge fund finance at Bristol Capital Advisors from 2004 to 2008, which during that period invested directly in more than 60 healthcare companies and was one of the most active investors in publicly-traded biotechnology companies.
Email Contact for Team
brooke@stevia-first.com
(530) 231-7800
CEO
5225 Carlson Rd., Yuba City, CA 95993
Chulpanovo Lab
Chulpanovo Village, Moscow region, Moscow
Team Name:
Chulpanovo Lab
Team Leader Name:
Eldar Kasumov, Ph.D.
Location
Chulpanovo Village, Moscow region, Russia
Approach:
ATP Synthesis
Affiliation:
KORVET
Link:
N/A
Team Leader Bio:
Kasumov Eldar A., Ph.D., is General Director of the Research and Production Center “KORVET”, which develops and manufactures products for animals.
Kasumov E.A. studied at the Azerbaijan State University (1977-1980) and Leningrad State University (1980-1983). He investigated a structure and function of proteins during post-graduate (1985-1988) at the Institute of Chemical Physics, Russian Academy of Sciences. He received his Ph.D. at Moscow State University (1991). Since 1989 at the Institute of Plant Physiology, Russian Academy of Sciences, he performed investigations in the field bioenergetics.
Email Contact for Team
kasumov_eldar@mail.ru
+74957926603
Research and Production Centre «KORVET»
142000, Moscow region, Domodedovo, Chulpanovo village, building 1
Froy – Chronobiology Laboratory
Jerusalem, Isreal
Team Name:
Froy – Chronobiology Laboratory
Team Leader Name:
Oren Froy, Ph.D.
Approach:
Effects of feeding regimens on circadian rhythms and longevity
Affiliation:
The Hebrew University, Jerusalem, Isreal
Team Leader Bio:
Dr. Froy’s post-doctoral fellowship was with Prof. Steven Reppert at Harvard Medical School and then at Department of Neurobiology at the University of Massachusetts Medical School. His post-doctoral training was in the field of neurobiology and focused on the molecular analysis of the biological clock in the brain of mammals and insects.
In October 2003 Dr. Froy joined the Institute of Biochemistry, Food Science, and Nutrition, at the Robert H Smith Faculty of Agriculture, Food and Environment, the Hebrew University of Jerusalem. He is currently focused on the relationship between the biological clock, nutrition, and aging.
Images
The Wowbagger Project (The Jackson Laboratory)
Bar Harbor, ME
Team Name:
THE WOWBAGGER PROJECT (The Jackson Laboratory)
Team Leader Name:
Ron Korstanje
Role:
Assistant Professor
Organization:
The Jackson Lab, a non-profit research institute
Approach:
TBA
Team Leader Bio:
The research in my lab focuses on the genetics of aging and age-related kidney disease using primarily mice, but also includes the use of C. elegans, zebrafish, and human data. Identifying the genes that are involved in the disease process and understanding their role are important in improving healthy aging. This focus is the result of my work on the genetics of cardiovascular disease in rabbit and mouse during my graduate and postdoctoral training, my work on the genetics of chronic kidney disease in rats and mice while being an assistant professor at the University Medical Center Groningen and at The Jackson Laboratory, and my role as the leader of the Translational Core of the Jackson Laboratory’s Nathan Shock Center of Excellence in the Basic Biology of Aging.
FUTICON
Berkeley, California
Team Name:
FUTICON
Team Leader Name:
Irina Convoy, PhD
Approach:
Oxytocin
Affiliation:
UC Berkeley
Link:
Team Leader Bio:
Irina Conboy received her PhD (Cellular and Molecular Immunology) from Stanford University in 1998. Dr. Conboy is an Assistant Professor of Bioengineering at UCB who joined the Department in November of 2004. Her research is focused on deciphering the key signal transduction pathways that control behavior of adult stem cells and understanding the age-related changes in this signal integration. This research program will ultimately lead to developing novel methods for combating the degenerative disorders that often accompany human aging. Since 2005 she is Faculty Mentor for UC Berkeley Chapter of Student Society for Stem Cell Research and sponsor of the Decal class: Stem cell science and Society. She is also Reviewer for CIRM Training Grant Program at UC Berkeley and a member of Peer Review Committee for State of Maryland Stem Cell Initiative, Invited peer-reviewer for Neurogenesis and Cell Fate study section at NIH, and Reviewer for Nathan Shock Center of Excellence in the Basic Biology of Aging. Irina Conboy received CIRM New Faculty Award in 2008, Glenn Award for Research in Biological mechanisms of aging in 2008 and Ellison’s Medical Foundation Award, New Scholar in Aging in 2005.
Images
<
CAI LAB
New York, NY
Team Name:
CAI LAB
Team Leader Name:
Dongsheng Cai, M.D., Ph.D.
Contact:
http://www.einstein.yu.edu/faculty/11603/dongsheng-cai/
Approach:
Hypothalamic Regulation
Affiliation:
Albert Einstein College of Medicine, New York, NY
Link:
http://www.einstein.yu.edu/faculty/11603/dongsheng-cai/
Team Leader Bio:
Dongsheng Cai, M.D., Ph.D., is professor in Department of Molecular Pharmacology and Institute of Aging, Albert Einstein College of Medicine. He received his medical training and Ph.D. in China from 1988 to 2000, and post-doctoral training at Joslin Diabetes Center, Harvard Medical School from 2000 to 2005. He was appointed as Assistant Professor in 2005 at University of Wisconsin-Madison before he was recruited to his current institution in 2008. Dr. Cai is an international leader in studying neural mechanism of aging as well as related metabolic syndrome.
IMAI LAB
St. Louis, MO
Team Name:
IMAI LAB
Team Leader Name:
Shin-Ichiro Imai, M.D., Ph.D.
Approach:
Gene Modification
Affiliation:
Washington University School of Medicine in St. Louis
Link:
http://dbbs.wustl.edu/faculty/Pages/faculty_bio.aspx?SID=5124
Team Leader Bio:
Dr. Imai has been studying molecular mechanisms of mammalian aging and longevity at cellular and organismal levels for 27 years and making significant contributions to the field of aging research. In 1987-1997, he studied cellular aging-associated transcriptional regulation in human fibroblasts and proposed the “Heterochromatin Island Hypothesis of Aging” (Imai and Kitano, 1998). To further expand his research, he joined the laboratory of Leonard Guarente at MIT as a Human Frontier Science Program Long-Term Fellow in 1997. In 1999, Lenny and he made a critical discovery of the NAD+-dependent protein deacetylase activity of yeast and mammalian SIR2 proteins (sirtuins) and published this landmark paper in Nature in 2000. This discovery opened a new field of aging research, and the field of sirtuin biology has been rapidly evolving in the past 10 years. In 2001, Dr. Imai joined the faculty of Washington University School of Medicine in St. Louis, Missouri. Since then, his laboratory has been devoted to studying the roles of the mammalian SIR2 ortholog SIRT1 and systemic NAD+ biosynthesis mediated by NAMPT, a key NAD+ biosynthetic enzyme, in the systemic regulation of aging and longevity in mammals.
Images
